Powered by the Evidence-based Practice Centers
Evidence Reports All of EHC
Evidence Reports All of EHC

SHARE:

FacebookTwitterFacebookPrintShare

Comparative Effectiveness and Safety of Oral Diabetes Medications for Adults With Type 2 Diabetes

Systematic Review ARCHIVED Jul 16, 2007
Download PDF files for this report here.

Page Contents

Archived: This report has been updated.

People using assistive technology may not be able to fully access information in this file. For additional assistance, please contact us.

Excerpt

We have performed a systematic review of published studies on the comparative effectiveness and safety of all oral diabetes medications. By comparing the short-term and long-term clinical effects of these medications, clinicians may have a better sense of how to choose among the oral diabetes medications. This review should be helpful as new classes of oral diabetes medications come on the market, such as the dipeptidyl peptidase-IV (DPP-IV) inhibitors. In addition, the results presented here may provide policymakers and insurers with better insight as they consider policies relating to medication coverage

Project Timeline

Comparative Effectiveness and Safety of Oral Diabetes Medications for Adults With Type 2 Diabetes

Jan 1, 2005
Topic Initiated
Jul 16, 2007
Systematic Review Archived
Page last reviewed December 2019
Page originally created November 2017

Internet Citation: Systematic Review: Comparative Effectiveness and Safety of Oral Diabetes Medications for Adults With Type 2 Diabetes. Content last reviewed December 2019. Effective Health Care Program, Agency for Healthcare Research and Quality, Rockville, MD.
https://effectivehealthcare.ahrq.gov/products/type-2-diabetes-medications-2007/research

Select to copy citation